Ribonucleotide Reductases, antagonists & inhibitors
- Name
- Ribonucleotide Reductases, antagonists & inhibitors
- Accession Number
- DBCAT000869
- Description
Not Available
- Drugs
Drug Drug Description Gemcitabine A nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. Didox Didox has been used in trials studying the supportive care of Gastric Cancer. - Drugs & Drug Targets